Researchers from Edith Cowan University (ECU) have developed an innovative new way to measure biological age, which could make it easier to detect and track age-related conditions.
When cancer spreads, tiny amounts of cells can break away from tumors and circulate in the bloodstream. A liquid biopsy is a means to detect the presence of cancer by detecting these cancer cells floating in blood samples. However, current state-of-the-art methods have necessitated trained specialists to comb through and review images of thousands of cells out of potentially millions of cells on a slide over a period of many hours.
Orthodontic treatment is most effective when timed to coincide with a child’s growth peak. Traditionally, clinicians estimate growth by examining X-ray images of the cervical vertebrae—the neck bones visible in routine dental radiographs. However, this process requires careful manual annotation of specific points on the bones, a task that is both time-consuming and prone to variation between observers.
A landmark international study led by the University of Zurich has shown that artificial intelligence can assess patient risk for the most common type of heart attack more accurately than existing methods. This could enable doctors to guide more personalized treatment decisions for patients.
When doctors analyze a medical scan of an organ or area in the body, each part of the image has to be assigned an anatomical label. If the brain is under scrutiny, for instance, its different parts have to be labeled as such, pixel by pixel: cerebral cortex, brain stem, cerebellum, etc. The process, called medical image segmentation, guides diagnosis, surgery planning and research.
For the first time, scientists can freeze-frame the exact moment an animal makes up their mind and commits to a choice—simply by looking at their brain activity.
Vara has announced that it has received a new CE certificate for its new breast-imaging AI.
Three presentations at ESMO 2025 will demonstrate Lunit SCOPE IO’s value in predicting immunotherapy response in colorectal, kidney, and lung cancer patients.
Health data helped identify kids in the ER who are likely to develop sepsis within 48 hours
CLEVELAND, Oct. 10, 2025 /PRNewswire/ — Surgical Theater, the leader in surgical XR visualization, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for SyncAR® Spine, the next-generation release of its spine platform. This clearance expands the system’s capabilities with advanced XR tools powered by AI algorithms. This brings patient MRI and CT directly into the operating room, aligning preoperative plans with intraoperative execution for greater clarity and control in spine surgery.